Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > What Kevin O'Leary said is worrisome
View:
Post by fdfd12 on Nov 03, 2015 7:52am

What Kevin O'Leary said is worrisome

He said "stocks like VRX and others who buy companies and sell drugs will have a lower multiple for many years because of this VRX problem and Hillary CLinton tweet."

Meaning, stocks use to have a PE of 15 to 20 now will now have compression.
Meaning they will only trade at multiples of 5-7 cause of this.

HCG in home mortgages has traded at a PE of 7 for a few years now.

I hope this is not the case because if it is, CXR will not see 60 for a year.

Comments please.
Comment by visionaryfool on Nov 03, 2015 8:06am
Even if that is true, you have to remember, its a double edge sword. Lower multiples will make acquisition cheaper as well which would mean even better bargins for shareholders in terms of free cash flow generation and in turn means faster debt payment. My personal opinion is that O'Leary is not a reputable investor but more of a media personality. I would take what he says with a grain of ...more  
Comment by calgamilton on Nov 03, 2015 12:43pm
Couldn't agree more about O'leary. Personally, I have never known him to be right about anything. He is an entertainer. Nothing more. His funds have a history of underperforming the index. He loves sensationalism but adds little in the way of knowledge or sound advice.
Comment by humbledude on Nov 03, 2015 8:09am
Well, to begin with, its hard to judge the value of a company that succeeds from multiple acquisition of other companies by using a traditional value model. Therefore, their value is judged by their past performance comparing to their sector.   In the pharma sector, in the case of CXR, the only number I as an investor will look at is their earning and profit.   If CXR puts the ...more  
Comment by TheRock07 on Nov 03, 2015 9:18am
WTF does he know ? He advised buying and did buy COS at $27. The meat is already displayed on the table. Health care is still  the best sector to be in and CXR has the most upside
Comment by Red_Deer on Nov 04, 2015 2:35am
Hey Moron this was well over 100 bucks a few months ago! This is what you call the BEST sector to be in????????!!!!!!!!!!!!!!!!!
Comment by Bullphighter on Nov 04, 2015 7:39am
easy pal
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities